IgG4 related cholangiopathy, a distinctive type of
cholangitis of unknown origin, is characterized by increased serum levels of
IgG4, massive infiltration of IgG4-positive plasma cells with storiform
fibrosis and/or obliterative
phlebitis in the thickened bile duct wall, and good response to
steroids. Patients with IgG4-cholangiopathy are frequently associated with
autoimmune pancreatitis; IgG4-cholangiopathy is recognized as a biliary manifestation of
IgG4-related disease. This condition can be diagnosed by a combination of imaging, serology, histopathology, and
steroid responsiveness; however, cholangiographic features are often difficult to differentiate from
primary sclerosing cholangitis,
pancreatic cancer, or
cholangiocarcinoma. The Japanese clinical diagnostic criteria for IgG4-related
sclerosing cholangitis established in 2012 are useful in the diagnosis of IgG4-cholangiopathy. Although the precise pathogenic mechanism remains unclear, the development of IgG4-cholangiopathy may involve: susceptible genetic factors, abnormal innate and acquired immunity, decreased naïve regulatory T cells, and specific B cell responses. Further studies on genetic backgrounds, disease specific
antigens, and the role of
IgG4 are necessary to clarify the pathogenesis.